Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patientsY Bécouarn, E Gamelin, B Coudert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of anthracyclines in the treatment of advanced ovarian cancerH J Lück, A Du Bois, B Weber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical dataM Chazal, S Cheradame, J L Formento, et al.
Seminars in Oncology|November 5, 1997
Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II studyE Pujade-Lauraine, J P Guastalla, B Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. A multicenter GINECO (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens) phase II studyJ P Guastalla, E Pujade-Lauraine, B Weber, et al.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2012
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601F Ferrand, D Malka, A Bourredjem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomyE Pujade-Lauraine, J P Guastalla, N Colombo, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 22, 2003
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]F Mornex, L Thomas, P Mohr, et al.
Melanoma Research|February 6, 2003
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanomaF Mornex, L Thomas, P Mohr, et al.
British Journal of Cancer|October 3, 1999
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)P Viens, T Palangié, M Janvier, et al.
Pageof 11